Disease Therapy Current Events

Disease Therapy Current Events, Disease Therapy News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
Higher risks for women with diabetes using HRT
Women with diabetes who use hormone replacement therapy are at an increased risk of death from all causes and heart disease, finds a study in this week's BMJ. (2003-02-20)

Pulmonary hypertension combination therapy may lead to greater disease burden
Patients with pulmonary arterial hypertension receiving combination therapy with intravenous PGI2 may suffer from greater disease burden compared with those receiving monotherapy or combination therapy, excluding IV PGI2. (2012-10-22)

Additional studies needed to evaluate CVD risks of hormone therapy for transgender patients
Additional studies needed to evaluate cardiovascular disease risks of long-term, hormone therapy for transgender patients (2017-07-24)

Cancer risk found for long-term hormone therapy
Using postmenopausal hormone therapy for more than 15 years increases a woman's risk of developing breast cancer, particularly among leaner women, according to research at the Keck School of Medicine of the University of Southern California. (2010-08-10)

Radiation Therapy Effective In Treating Advanced Stages Of Melanoma
Radiation therapy prevents local relapses of melanoma (skin cancer) and also improves the quality of life of patients whose disease has spread, a new study in Germany has found. (1997-10-03)

Local therapy followed by treatment with EGFR TKI is well tolerated
A recent study published in the March 2013 issue of the International Association for the Study of Lung Cancer's Journal of Thoracic Oncology, found that EGFR- mutant lung cancers with acquired resistance to EGFR TKI therapy are amenable to local therapy to treat oligometastatic disease when used in conjunction with continued EGFR inhibition. (2013-02-21)

Rapidly rising PSA before treatment is key indicator of cancer spread
Results of a new Fox Chase Cancer Center study show that men with a rapidly rising PSA level before treatment have a high probability of metastatic disease and should receive hormone therapy in addition to radiation. (2006-11-08)

Collaboration of therapists and clients may improve family therapy
A new article addresses ongoing conversations about bridging the gap between practice and research within the field of family therapy. (2017-07-18)

Psychological support helps adolescents with chronic fatigue syndrome
Psychological support, in the form of cognitive behaviour therapy, is an effective treatment for adolescents with chronic fatigue syndrome. (2004-12-06)

HRT may prevent endometrial cancer
The long-term use of hormone replacement therapy (HRT) does not increase the risk of endometrial cancer and may even protect the endometrium (the lining of the uterus) from the disease, concludes a study in this week's BMJ. (2002-08-01)

Early hormone therapy best for men with aggressive prostate cancer
Men with aggressive, metastatic prostate cancer who receive immediate early hormone therapy live on average three to four years longer than others who delay similar treatment, according to researchers at the University of Rochester. (2004-06-10)

Study examines safety and effectiveness of infliximab biosimilar in patients with inflammatory bowel
Biosimilars are biologic agents that highly similar to original biomedical medications (oringinators), but are much cheaper. (2017-12-06)

DBS treatment may slow the progression of Parkinson's tremor in early-stage patients
Deep brain stimulation (DBS) may slow the progression of tremor for early-stage Parkinson's disease patients, according to a Vanderbilt University Medical Center study released in the June 29 online issue of Neurology®, the medical journal of the American Academy of Neurology. (2018-06-29)

Early Parkinson's patients waiting too long to seek medical evaluation
Too many early Parkinson's disease (PD) patients are treating symptoms before they appear, shrinking the pool of candidates for clinical trials and limiting the chances for a cure. (2018-09-28)

Study shows a serious risk of side effects when having latent tuberculosis therapy over age 65
A new study found that there is a serious increased risk of side effects requiring hospitalization in people over the age of 65 who are going through latent tuberculosis infection therapy, according to a study published in Canadian Medical Association Journal. (2011-01-10)

Further evidence that HRT does not protect against cardiovascular disease
Results of a UK randomised trial published on THE LANCET's website-(2002-12-16)

Realizing the potential of gene therapy for neurological disorders
Promising findings from preclinical animal studies show the potential of gene therapy for treating incurable neurological disorders. In new research presented today, scientists successfully used gene therapy to slow the progression and improve symptoms of disorders such as amyotrophic lateral sclerosis and Parkinson's disease. The findings were presented at Neuroscience 2018, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health. (2018-11-04)

Inappropriate sepsis therapy leads to fivefold reduction in survival
New research from the November issue of CHEST shows that patients with septic shock may have a fivefold reduction in survival. (2009-11-05)

Online therapy helped cardiovascular disease patients with depression
Researchers at Linköping University have developed a treatment for depression among people with cardiovascular disease. The results, recently published in JMIR Mental Health, show that cardiovascular disease patients who underwent internet-based therapy for their depression became less depressed and gained a better quality of life. (2019-12-04)

Additional hormone therapy use after radiation for some prostate cancers extends survival
The largest study examining the benefits of long-term use of hormone therapy after radiation treatment for prostate cancer shows men with aggressive locally advanced disease live longer if hormones are used for an additional 24 months. Research also showed other significant benefits for those with less aggressive cancers who receive hormones. (2006-11-06)

People who are obese or former smokers more likely to follow recommended statin therapy
A new study suggests that lifestyle factors can help predict whether people will adhere to statin therapy for high cholesterol. Among people without heart disease and diabetes, those who are overweight, obese or former smokers are more likely to adhere to statin therapy, according to an article in CMAJ. (2014-06-23)

Radiation plus hormonal therapy more effective than radiation alone for certain prostate cancer patients
A combination of radiation and hormonal therapy is more effective than radiation alone for certain prostate cancer patients with more aggressive disease, a Radiation Therapy Oncology Group (RTOG) study has found. The study was presented at the American Society for Therapeutic Radiology and Oncology Annual Meeting in Boston, Mass. on October 25 at 9:10 a.m. (2000-10-24)

U of M study shows why treatment isn't effective for HIV
University of Minnesota researchers have answered a key question as to why antiretroviral therapy isn't effective in restoring immunity in HIV-infected patients. Once a person is infected with the virus, fibrosis, or scarring, occurs in the lymph nodes -- the home of T cells that fight infection. And once fibrosis occurs, T cells can't repopulate the lymph nodes when HIV therapy begins, said Timothy Schacker, M.D., professor of medicine and principal investigator on the study. (2008-08-05)

Study: Hormone therapy may not protect against Alzheimer's disease
The latest study on hormone therapy and Alzheimer's disease shows no relationship between taking the drugs and whether you may develop the disease years later. Some previous studies have shown that hormone therapy may increase the risk of the disease, while others have shown that it may reduce the risk. The new study was published in the Feb. 15, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology. (2017-02-15)

Gene therapy 'turns off' mutation linked to Parkinson's disease
A group of Northwestern University researchers is developing a novel gene therapy aimed at selectively turning off one of the genes involved in the development of Parkinson's disease. (2006-01-18)

Oral estrogen hormone therapy linked to increased risk of gallbladder surgery in menopausal women
Oral estrogen therapy for menopausal women is associated with an increased risk of gallbladder surgery, according to a large-scale study of more than 70 000 women in France published in CMAJ (Canadian Medical Association Journal). (2013-03-18)

Psychotherapy via the Internet as good as if not better than face-to-face consultations
Online psychotherapy is just as efficient as conventional therapy. Three months after the end of the therapy, patients given online treatment even displayed fewer symptoms. For the first time, clinical researchers from the University of Zurich provide scientific evidence of the equal value of internet-based psychotherapy. (2013-07-30)

Fertility therapy not associated with long-term cardiovascular disease
Women who gave birth following fertility treatment had no long-term increased risk of death or major cardiovascular events compared to women who gave birth without fertility therapy, according to new research by the Institute for Clinical Evaluative Sciences and Women's College Hospital. (2013-07-31)

Timing is everything: Hormone use may reduce or increase Alzheimer's disease risk in women
A new study suggests that women who begin taking hormone therapy within five years of menopause may reduce their risk of developing Alzheimer's disease. The research is published in the Oct. 24, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology. (2012-10-24)

Manual therapy is effective treatment for neck pain
Manual therapy is more effective and less costly for treating neck pain than physiotherapy or care by a general practitioner, claim researchers in this week's BMJ. (2003-04-24)

Testosterone therapy may prevent Alzheimer's disease
Researchers at the University of Southern California have discovered a direct link between loss of testosterone and the development of an Alzheimer's-like disease in mice. They also discovered that testosterone treatment slows progression of the disease. The study, published in the Dec. 20 issue of the Journal of Neuroscience, predicts that testosterone-based hormone therapy may be useful in the treatment and prevention of Alzheimer's disease in aging men. (2006-12-19)

Targeted drug may prolong survival of patients with cervical cancer
A new clinical study has found that erlotinib, a targeted antitumor agent, has promising potential to improve treatment for cervical cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the results indicate that larger trials are warranted to determine whether the drug should become part of standard therapy for women with the disease. (2014-03-10)

Cell therapy trial offers new hope to liver disease patients
Researchers from the University of Edinburgh have received funding to start testing a new cell therapy to treat patients with liver disease. A clinical trial will begin within the next year. (2014-11-24)

MCW researcher to study gene therapies for hemophilia
A researcher at the Medical College of Wisconsin (MCW) has received a four-year, $1.5 million dollar grant from the National Institutes of Health's National Heart, Lung, and Blood Institute to continue her study of blood platelet gene therapies for hemophilia A, a genetic bleeding disorder. (2015-05-26)

Gene replacement therapy offers viable treatment option for fatal disease
Spinal muscular atrophy (SMA) is a disease that causes progressive degeneration in the nerve cells that control muscles, thereby causing muscle weakness and eventually death. SMA affects approximately 200,000 people in the US, often children. Now, researchers at the University of Missouri are studying a subtype of SMA, spinal muscular atrophy with respiratory distress type 1 (SMARD1), and have developed a gene replacement therapy that can be used to treat and control the disease in the future. (2016-05-05)

Risk of breast cancer with HRT may be lower than we think
A woman's risk of developing breast cancer while taking hormone replacement therapy may be lower than we think, suggest researchers in this week's BMJ. (2005-08-04)

MADIT-CRT trial
Asymptomatic or mildly symptomatic cardiac patients randomized to an implanted cardiac resynchronization device with defibrillator have a 34 percent lower risk of heart failure or death than those receiving a standard implanted cardioverter defibrillator, according to results from the MADIT-CRT study. (2009-09-01)

Aspirin protects patients at high risk of heart attack or stroke
Aspirin (or another antiplatelet drug) protects patients at high risk of serious vascular events, such as heart attack or stroke, and should be considered routinely for all such patients, concludes a study in this week's BMJ. (2002-01-10)

Hormone therapy may be hazardous for men with heart conditions
Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk prostate cancer. However, adding hormone therapy may reduce overall survival in men with pre-existing heart conditions, even if they have high-risk prostate cancer according to a new study just published online in advance of print in the International Journal of Radiation Oncology•Biology•Physics, the official scientific journal of ASTRO. (2011-07-26)

Breast cancer patients still have risk of relapse after 5 years of systemic therapy
Breast cancer survivors continue to have a substantial risk of disease recurrence after five years of systemic therapy, according to a study published in the August 12 online issue of the Journal of the National Cancer Institute. Among breast cancer patients who were cancer-free five years after initiating systemic therapy, 89 percent remained recurrence-free at five years (approximately 10 years after a woman's initial diagnosis) and 80 percent remained recurrence free at 10 years (approximately 15 years after diagnosis). (2008-08-12)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.